TickerFacts.

NeoGenomics Inc (NEO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

$11.91M
Year ended 2020-12-31
-13.6%
3-year compound annual growth
$33.35M2012-12-31: $4.85M2013-12-31: $7.36M2014-12-31: $7.56M2015-12-31: $1.09M2016-12-31: $18.09M2017-12-31: $18.50M2018-12-31: $25.84M2019-12-31: $33.35M2020-12-31: $11.91M$11.91M
2012-12-31 EBITDA (USD) 2020-12-31
Period endedEBITDAChange YoYSource filing
2020-12-31$11.91M-64.3%2023-02-24, From 2020-01-01
2019-12-31$33.35M+29.1%2022-02-25, From 2019-01-01
2018-12-31$25.84M+39.7%2021-02-25, From 2018-01-01
2017-12-31$18.50M+2.2%2020-02-28, From 2017-01-01
2016-12-31$18.09Mn/c2019-02-26, From 2016-01-01
2015-12-31$1.09M-85.5%2018-03-13, From 2015-01-01
2014-12-31$7.56M+2.7%2017-03-14, From 2014-01-01
2013-12-31$7.36M+51.9%2016-04-18, From 2013-01-01
2012-12-31$4.85Mn/a2015-03-03, From 2012-01-01